Market revenue in 2023 | USD 140.4 million |
Market revenue in 2030 | USD 193.2 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Disposable |
Fastest growing segment | Reusable |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable, Reusable |
Key market players worldwide | Medtronic PLC, Johnson & Johnson, Getinge AB Class B, Baxter International Inc, Mizuho Financial Group Inc, Péters Surgical, Carponovum, Vascular Graft Solutions, Medline Industries, Seger Surgical Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anastomosis devices market will help companies and investors design strategic landscapes.
Disposable was the largest segment with a revenue share of 88.89% in 2023. Horizon Databook has segmented the UK anastomosis devices market based on disposable, reusable covering the revenue growth of each sub-segment from 2018 to 2030.
The UK anastomosis devices market is expected to grow lucratively at a CAGR of 5.8% over the forecast period. Rise in adoption of anastomosis devices by physicians for performing CABG surgery is considered as one of the primary drivers for the growth of anastomosis devices market in the UK.
According to British Heart Foundation, CVD is responsible for more than 26% of the total deaths in the UK. The total number of operations performed for the treatment of CHD is increasing in the UK. According to the report “The epidemiology of cardiovascular disease in the UK 2014” published by BMJ Publishing Group Ltd & British Cardiovascular Society, over 17,000 CABG procedures were carried out in the UK in 2012 and the number is expected to decline gradually.
Despite the substantial shift toward percutaneous coronary interventions in the past years, CABG procedures are still considered as one of the major surgical treatments for complex conditions. Owing to the aforementioned factors, the market for anastomosis device in the UK is expected to grow lucratively.
Horizon Databook provides a detailed overview of country-level data and insights on the UK anastomosis devices market , including forecasts for subscribers. This country databook contains high-level insights into UK anastomosis devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account